Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 20/07/2026
In
Objective
To achieve long-term capital growth by investing in biotechnology and other life sciences companies.
AIC sector
Management group
Company website
Launch date
06/05/1994
August
Domicile
United Kingdom
Fund manager
Ailsa Craig, Marek Poszepczynski
Dividend frequency
Semi-Annually
Wind-up provisions
The Association Articles of the company provide for Directors to put forward a proposal for the continuation of the company at the AGM at two-yearly intervals. The upcoming continuation vote is scheduled for the December 2027 AGM.
Continuation vote
2 yearly
(Next vote: 2027)
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 349.83 | 395.25 | 1,100.00 | 1,172.65 | -6.19 | 0 | 2.85 | Jul, Dec | 1.3 (31/08/2025) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 23/07/2026 | 21/08/2026 | 15.670 | No | 2026 |
| 29/12/2025 | 23/01/2026 | 15.640 | No | 2026 |
| 24/07/2025 | 22/08/2025 | 16.170 | No | 2025 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| International Biotechnology | Share price total return | 74.2 | 90.8 | 78.9 | 225.5 |
| Healthcare & Biotechnology AIC sector | Share price total return | 37.2 | 20.3 | -1.5 | 96.7 |
Scroll
Share structure
Number of shares
31,802,834
9,580,983
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 27,744 | 1,880,802 | 23,055,771 | 84,787,612 |
| Average | N/A | 89,562 | 91,130 | 67,238 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 0.31 | 20.91 | 198.99 | 605.86 |
| Average | N/A | 1.00 | 0.79 | 0.48 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GB0004559349 | IBT | GBX | London Stock Exchange - MAIN Chi-x Europe Limited London Stock Exchange |
Scroll
Top holdings
Data as at : 30/06/2026
| Investment | % of total assets |
|---|---|
| Insmed Inc | 6.2 |
| Alnylam Pharmaceuticals Inc | 5.3 |
| Madrigal Pharmaceuticals Inc | 4.5 |
| Gilead Sciences Inc | 4.5 |
| Vera Therapeutics Inc Class A | 4.4 |
| Travere Therapeutics Inc Ordinary Shares | 4.4 |
| Crinetics Pharmaceuticals Inc | 3.6 |
| Rhythm Pharmaceuticals Inc | 3.6 |
| Supernus Pharmaceuticals Inc | 3.5 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
